deltatrials
Completed NA INTERVENTIONAL 3-arm NCT04737915

Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights

Comparing the Efficacy of a Single-Session Virtual Reality Treatment for Fear of Heights to In Vivo Exposure and No Treatment

Sponsor: University of Notre Dame

Conditions Acrophobia Anxiety Disorder Fear of Heights Specific Phobia
Interventions Exposure Therapy (In Vivo) Exposure Therapy (Virtual Reality)
Updated 3 times since 2021 Last updated: Feb 3, 2021 Started: Jun 11, 2018 Primary completion: Mar 6, 2019 Completion: Mar 6, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acrophobia and Anxiety Disorder and is currently completed. University of Notre Dame leads this study, which shows 3 recorded versions since 2018 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2021 — Jul 2024 [monthly]

    Completed NA

    First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Notre Dame
Data source: University of Notre Dame

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations